• OPEN AN ACCOUNT
Indian Indices
Sensex
77,301.40 383.55
( 0.50%)
Global Indices
Nasdaq
51,780.49 -224.49
(-0.43%)
Dow Jones
7,583.75 21.35
(0.28%)
Hang Seng
62,088.48 -993.38
(-1.57%)
Nikkei 225
10,659.07 -102.26
(-0.95%)
Forex
USD-INR
94.80 -0.14
(-0.14%)
EUR-INR
106.11 0.21
(0.20%)
GBP-INR
127.09 0.00
(0.00%)
JPY-INR
0.60 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3851573
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
17.23
130.87
EPS(TTM)
Face Value()
Div & Yield %
4.77
10
1.46
 

Anmol India standalone net profit rises 56.88% in the March 2026 quarter
May 18,2026
Net profit of Anmol India rose 56.88% to Rs 2.51 crore in the quarter ended March 2026 as against Rs 1.60 crore during the previous quarter ended March 2025. Sales declined 1.82% to Rs 308.51 crore in the quarter ended March 2026 as against Rs 314.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 61.66% to Rs 11.30 crore in the year ended March 2026 as against Rs 6.99 crore during the previous year ended March 2025. Sales rose 11.17% to Rs 1416.57 crore in the year ended March 2026 as against Rs 1274.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales308.51314.23 -2 1416.571274.26 11
OPM %0.911.42 -1.351.25 -
PBDT3.692.53 46 15.9510.02 59
PBT3.512.35 49 15.269.55 60
NP2.511.60 57 11.306.99 62